| Financial Year |
March 31 2023 |
| Monetary Funds |
749,975,352.49 |
| Held-for-trading Financial Assets |
41,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
525,124,088.09 |
| Advances to Suppliers |
28,182,406.95 |
| Other Receivables |
17,313,326.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
467,824,887.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,676,686.31 |
| Total Current Assets |
1,904,462,271.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,873,176.16 |
| Investment Properties |
18,705,580.94 |
| Fixed Assetes |
895,603,293.14 |
| Under-construction Projects |
57,246,264.46 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
96,437,563.34 |
| R&D expenses |
-- |
| Goodwill |
82,011,402.41 |
| Long-Term Deferred and Prepaid Expenses |
44,109,601.25 |
| Deferred Income Tax Assets |
91,039,211.08 |
| Other Non-Current Assets |
19,480,964.98 |
| Sub-Total of Non-Current Assets |
1,319,396,034.31 |
| Total Assets |
3,223,858,306.07 |
| Short-Term Loans |
665,056,084.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
73,296,211.72 |
| Accounts Payable |
318,618,324.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,666,570.90 |
| Taxes Payable |
8,474,886.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,091,430.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
51,985,591.60 |
| Other Current Liabilities |
1,463,064.76 |
| Sub-Total of Current Liabilities |
1,200,766,936.18 |
| Long-term Loans |
70,105,812.30 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,200,000.00 |
| Deferred Income Tax Liabilities |
14,303,438.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
210,289,725.41 |
| Total Liabilities |
1,411,056,661.59 |
| Paid-In Capital(Or Share Stock) |
259,662,286.00 |
| Capital Surplus |
1,714,928,789.77 |
| Surplus Reserve |
46,659,767.92 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-292,719,718.12 |
| Minority Stockholder's Interest |
84,270,518.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,728,531,125.57 |
| Owner's Equity（Stockholder's Equity） |
1,812,801,644.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,223,858,306.07 |
